RxSight, Inc.
RXST
$14.01
$0.6955.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.41% | 40.71% | 59.08% | 67.65% | 68.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.41% | 40.71% | 59.08% | 67.65% | 68.75% |
| Cost of Revenue | 8.37% | 4.58% | 19.20% | 20.94% | 23.92% |
| Gross Profit | 36.95% | 63.07% | 83.67% | 101.83% | 99.55% |
| SG&A Expenses | 22.77% | 33.19% | 33.76% | 33.14% | 43.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.87% | 23.86% | 28.32% | 25.51% | 31.37% |
| Operating Income | -0.04% | 20.49% | 26.26% | 38.84% | 18.53% |
| Income Before Tax | 10.11% | 35.55% | 49.00% | 56.00% | 31.19% |
| Income Tax Expenses | 100.00% | 166.67% | 8.33% | -38.46% | -- |
| Earnings from Continuing Operations | 10.00% | 35.29% | 48.95% | 55.96% | 31.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.00% | 35.29% | 48.95% | 55.96% | 31.12% |
| EBIT | -0.04% | 20.49% | 26.26% | 38.84% | 18.53% |
| EBITDA | -3.59% | 17.22% | 29.19% | 40.48% | 21.31% |
| EPS Basic | 18.14% | 42.36% | 54.24% | 60.48% | 40.85% |
| Normalized Basic EPS | 18.22% | 42.55% | 48.42% | 59.48% | 40.92% |
| EPS Diluted | 18.14% | 42.36% | 54.24% | 60.48% | 40.85% |
| Normalized Diluted EPS | 18.22% | 42.55% | 48.42% | 59.48% | 40.92% |
| Average Basic Shares Outstanding | 9.95% | 12.22% | 11.57% | 11.47% | 16.46% |
| Average Diluted Shares Outstanding | 9.95% | 12.22% | 11.57% | 11.47% | 16.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |